<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-Z9SKRLKL</identifier><date>2023</date><creator>Janžič, Andrej</creator><relation>documents/doc/Z/URN_NBN_SI_doc-Z9SKRLKL_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-Z9SKRLKL_001.txt</relation><format format_type="volume">16</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 19-25</format><identifier identifier_type="DOI">10.18690/actabiomed.259</identifier><identifier identifier_type="COBISSID">178216451</identifier><identifier identifier_type="ISSN">1855-5640</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-Z9SKRLKL</identifier><language>eng</language><publisher publisher_location="Maribor">Univerzitetna založba Univerze v Mariboru</publisher><source>Acta medico-biotechnica</source><rights>BY</rights><subject language_type_id="eng">access to medicines</subject><subject language_type_id="slv">dostopnost zdravil</subject><subject language_type_id="slv">financiranje zdravil</subject><subject language_type_id="eng">health technology assessment</subject><subject language_type_id="eng">joint clinical assessment</subject><subject language_type_id="eng">medicines funding</subject><subject language_type_id="slv">postopek razvrščanja</subject><subject language_type_id="eng">reimbursement procedure</subject><subject language_type_id="slv">skupne klinične ocene</subject><subject language_type_id="slv">vrednotenje zdravstvenih tehnologij</subject><title>Dostopnost inovativnih zdravil v Sloveniji</title><title>Access to innovative medicines in Slovenia</title></Record>